Nile blue sulphatase test in amniotic fluid is for the following:
## Core Concept
The Nile blue sulphatase test, also known as the Nile blue sulfate test, is a diagnostic tool used to detect the presence of certain conditions in a fetus by analyzing the amniotic fluid. This test is specifically related to the assessment of fetal maturity and the detection of potential fetal distress or conditions like **erythroblastosis fetalis**. The test involves assessing the concentration of bilirubin in the amniotic fluid, which can be an indicator of fetal hemolysis.
## Why the Correct Answer is Right
The correct answer, **C.**, corresponds to the condition for which the Nile blue sulphatase test is utilized. This test is particularly useful in the context of **Rh hemolytic disease of the newborn (HDN)**, also known as erythroblastosis fetalis. In this condition, the mother's immune system produces antibodies against the Rh-positive red blood cells of her fetus, leading to hemolysis (breakdown) of these cells. The breakdown products, including bilirubin, can be detected in the amniotic fluid. The test helps in assessing the severity of the condition and guides management decisions.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because, although assessing fetal lung maturity is an important aspect of managing pregnancies, especially those at risk of preterm delivery, it is not the primary purpose of the Nile blue sulphatase test.
- **Option B:** This option is incorrect because, while infections can be detected through amniotic fluid analysis, the Nile blue sulphatase test is not primarily used for this purpose.
- **Option D:** This option is incorrect as it does not directly relate to the primary application of the Nile blue sulphatase test in clinical practice.
## Clinical Pearl / High-Yield Fact
A key point to remember is that the **L/S ratio (lecithin-sphingomyelin ratio)** is another test performed on amniotic fluid, but it is used to assess **fetal lung maturity**, not directly related to the detection of hemolytic disease of the newborn. The clinical scenario and specific test indications guide the choice between these and other diagnostic tests.
## Correct Answer: C.